Forecast & Rating4 analysts currently cover Rani Therapeutics, of which 4 give a positive rating. The average price target is $7.20, about 708.1% upside from the current price of $0.89. Coverage is limited, so the data is for reference only. Data as of Aug 24, 2026; this does not constitute investment advice.
Aug 21, 2026Price forecast
$7.20708.08%
Forecast & RatingStrong buy
4analysts
- Strong buy75.00%
- Buy25.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 23, 2026
Forecast met5.0%
Stock price$0.89
Avg. target$9.3
High target$11
Low target$7
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.